Edwards Lifesciences vs Medline
Edwards Lifesciences (EW) and Medline (MDLN) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $58.6B
- Last close
- $101.85
- 12 months
- +21.1%
- Market value
- $48.7B
- Last close
- $37.04
- 12 months
- —
At a glance
- The biggest part of Edwards Lifesciences's revenue is Transcatheter Aortic Valve Replacement (74%); at Medline it is Supply Chain Solutions (52%).
- Edwards Lifesciences and Medline are close in size by market value ($58.6B and $48.7B).
- In their last fiscal years Edwards Lifesciences kept 17.7% of revenue as net income and Medline 4.1%.
- In the last 90 days insiders reported 0 open-market purchases at Edwards Lifesciences and 0 at Medline; members of Congress disclosed 0 trades in Edwards Lifesciences and 0 in Medline.
- Next results: Edwards Lifesciences Feb 8, 2027, Medline Feb 23, 2027.
How each one makes money: Edwards Lifesciences revenue · Medline revenue
Share prices on one chart
Edwards Lifesciences and Medline, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Edwards Lifesciences EWNYSE · Health Care Equipment | Medline MDLNNASDAQ · Surgical & Medical Instruments & Apparatus | |
|---|---|---|
| Size and profitability | ||
| Market value | $58.6B | $48.7B |
| Revenue, last fiscal year | $6.07B | $28.4B |
| Net income, last fiscal year | $1.07B | $1.16B |
| Net marginNet income as a share of revenue | 17.7% | 4.1% |
| Free cash flow | $1.33B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Edwards Lifesciences against
Common questions
How is Edwards Lifesciences different from Medline?
Edwards Lifesciences (EW) is in Health Care Equipment on NYSE, with $6.07B of revenue in its last fiscal year and a net margin of 17.7%. Medline (MDLN) is in Surgical & Medical Instruments & Apparatus on NASDAQ, with $28.4B of revenue in its last fiscal year and a net margin of 4.1%. The biggest part of Edwards Lifesciences's revenue is Transcatheter Aortic Valve Replacement (74%); at Medline it is Supply Chain Solutions (52%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Edwards Lifesciences and Medline compare in size?
Edwards Lifesciences has the larger market value: Edwards Lifesciences $58.6B and Medline $48.7B, at the last close.
Whose share price rose more over the last 12 months, EW or MDLN?
A 12-month price change is not available for both companies.
Which has had more insider buying, Edwards Lifesciences or Medline?
Since 2006, Edwards Lifesciences insiders reported 12 open-market purchases against 0 for Medline. These are counts of what was filed, not a view on either stock.
Do members of Congress trade EW or MDLN?
In the last 12 months, members of Congress disclosed 2 trades in Edwards Lifesciences (EW) and 0 in Medline (MDLN).
When did insiders last buy EW and MDLN?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Edwards Lifesciences pageMedline pageRare insider trades this weekAll comparisons
https://oqro.io/compare/ew-vs-mdln







